Company intelligence / Profile preview

Ceyeber

Ownership: Private
Development stage: Other

Overview

Ceyeber is developing an implantable smart intraocular lens intended to function as a bionic/augmented intraocular device to address blindness and low vision; products are described as in development and preparing for medical use, with no human clinical trial results publicly reported yet.[7][6][4]

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Ceyeber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceyeber.

Explore the full profile